Table 1 Basic characteristics of the study participants with pleural effusion, n = 194; cases = 214
From: Multiplex bacterial polymerase chain reaction in a cohort of patients with pleural effusion
N = 194 | Missing data | |
|---|---|---|
Age, y | 68.8 ± 15.5 | 0 |
Male | 112 (58) | 0 |
unadjusted Charlson Score | 4.8 ± 2.7 | 0 |
ASA Score | 3.1 ± 0.44 | 0 |
Length of hospital stay, days | 16.0 (7.0;27.5) | 0 |
Smoking status | 10 | |
Current smoker | 42 (22) | |
Non-smoker | 61 (31) | |
Immune status | ||
Immunosuppressed | 40 (18.6) | 1 |
Signs and symptoms | 2 | |
Cough | 91 (43) | |
Sputum | 56 (26) | |
Fever | 58 (27) | |
Chest pain | 53 (25) | |
Blood parameters | ||
Performed | 206 (96) | 8 |
Leucocytes (*109/l) | 10.4 ± 7.6 | 0 |
Neutrophils (*109/l) | 7.9 ± 5.5 | 32 |
C-reactive protein (mg/l) | 118.1 ± 109.8 | 3 |
Lactate dehydrogenase (U/l) | 287.4 ± 208.9 | 6 |
Pleural fluid parameters | ||
Performed | 214 (100) | |
Transudate | 51 (26) | 7 |
Exudate | 146 (74) | 7 |
Protein (g/l) | 34.2 ± 11.6 | 7 |
Glucose (mmol/l) | 5.6 ± 2.9 | 26 |
pH | 7.3 ± 0.23 | 35 |
pH ≤ 7.2 | 37 (21) | 35 |
Lactate dehydrogenase (U/l) | 1047.9 ± 3895.3 | 20 |
Anti-infective therapy before sampling | 130 (61) | 0 |
Antibiotics | 128 (60) | 0 |
Anti-fungal | 11 (5) | 0 |
Anti-viral | 10 (5) | 0 |
Duration of antibiotic therapy | ||
Before sampling | 1 [0;7] | 1 |
After sampling | 8 [0;21] | 0 |
Total | 14 [0;34] | 1 |
Final clinical diagnosis | ||
Empyema | 61 (29) | 0 |
Therapeutic regime | ||
Conservative | 175 (82) | 0 |
Operative | 39 (18) | 0 |
Drainage | 158 (74) | 0 |
Medical Thoracoscopy | 83 (39) | 0 |
Outcomes | ||
In-house mortality within 30 days of sampling | 18 (9.3) | 0 |
Re-hospitalisation within 90 days of discharge | 68 (35) | 0 |
Operation within 60 days of sampling | 57 (27) | 0 |